Sanofi
Use of neuroglobin agonist for preventing or treating mitochondrial RCCI and/or RCCIII deficiency disease

Abstract:

The present invention concerns a neuroglobin agonist for use in the treatment or prevention of a mitochondrial disease associated with respiratory chain complex I (RCCI) deficiency and/or respiratory chain complex III (RCCIII) deficiency.